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Abstract The standard surgical management of hip
fractures is associated with tissue trauma and bleeding
which are added to the fracture injury. The percutaneous
compression plate (PCCP) is a minimally invasive device
that has been demonstrated in previous studies to reduce
postoperative complications and blood loss. This prospec-
tive, multi-center, observational study assessed clinical and
functional outcomes with PCCP as treatment for trochan-
teric fractures. Patients with a stable or unstable proximal
femoral fracture of type AO 31.A1 or 31.A2 were enrolled
in eight hospitals in Italy. The primary outcome of interest
was the recovery of the pre-fracture functional status at
1-year follow-up; secondary outcomes of interest included
blood transfusions, surgical time, complications, and
mortality. A total of 273 patients were enrolled. The ASA
score was 3 or 4 in 72.5 % of patients. The mean surgical
time was 44.1 min; the mean post-surgery blood transfu-
sions was 0.9 units. At 1 year, 48 patients (17.6 %) died,
28 (10.2 %) were lost to follow-up, 4 patients (1.5 %) were
excluded, hence 193 patients (70.3 %) were available for
final evaluation. At the 1-year follow-up visit, 51.9 % of
patients recovered or improved their pre-fracture modified
Harris Hip Score, 49.1 % of patients improved or main-
tained their walking abilities, and 66.6 % of patients
residing at home pre-surgery maintained their domicile.
The overall mortality rate was 17.6 %. Major complica-
tions included two fracture collapses, one excessive sliding
of the cephalic screw leading to a partial fracture collapse
and one back-out of the diaphyseal screw. This study
demonstrates that treatment of trochanteric fractures with
PCCP gives good outcomes and significant advantages
such as low blood loss, short surgical time, low risk of
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complications, and good functional recovery in the
majority of the patients.
Keywords Functional recovery  Percutaneous
compression plate  Intertrochanteric femoral fracture 
Reduced blood loss  Reduced transfusions 
Femoral fixation
Introduction
Hip fractures are common worldwide [1], with a higher
incidence expected in the next few decades due to longer
life expectancy and an increase in the geriatric population
[2]. Hip fractures usually involve the femoral neck or the
trochanteric region and are associated with increased
morbidity and mortality, especially in the elderly popula-
tion [3]. The primary goal of treatment is to obtain an
early restoration of the patient’s pre-fracture status, which
is best accomplished by early mobilization following
surgery [4, 5]. The painful and disabling nature of the hip
fractures needs surgical management, even in those
patients with little potential for functional recovery [6].
Surgical treatment aims at restoring the ambulatory skills
of the patient, and the post-surgical outcomes have been
related to stabilization and accuracy of fracture reduction
[7]. Beringer et al. [8] reported that the recovery of pre-
injury mobility in hip fractures was influenced by the
patient’s American Society of Anesthesiologists (ASA)
score, age, and domicile status. The functional outcomes
following hip fractures in elderly patients have been pre-
viously evaluated considering their 1-year mortality rate,
recovery of pre-fracture ambulatory status, need for
nursing home care, and the ability to live independently
[9]. It has been shown that maximum functional recovery
occurs within 6 months post-fracture [10], but continues
for at least 1 year in some physical and instrumental
functions, and beyond 1 year in the patient’s daily phys-
ical activities [11].
The surgical treatment of trochanteric hip fractures
includes a wide variety of implants and fixation strategies
[12]; however, most of these devices and techniques are
invasive, are associated with high tissue trauma and high
incidence of bleeding, and may worsen the existing
comorbidities in elderly patients [13] with the risk of delay
in the recovery from the fracture. Therefore, methods of
osteosynthesis that reduce the amount of tissue injury,
bleeding, and complications, and ensuring a mechanical
stability allows early mobilization and rapid return to pre-
injury levels of independence are preferred [14]. In an
attempt to reduce mortality and accelerate rehabilitation,
Gotfried [15, 16] developed the percutaneous compression
plate (PCCP), which is a device for minimal-approach
osteosynthesis of trochanteric hip fractures [17]. PCCP
provides a complete fracture stabilization and fixation,
against bending as well as rotational forces, thanks to the
presence of two cervical screws, the small screw diameter,
that spares bone, and the strength of the plate, that permit
full-weight bearing immediately post-surgery [16].
Percutaneous compression plate consists of a plate with
three diaphyseal screws and two sliding cephalic screws
which are set at a 135 degree angle to allow and facilitate
controlled fracture compression. PCCP is indicated for the
treatment of trochanteric fractures with intact lateral walls
(classified as AO 31.A1 and 31.A2) [18, 19]. The advan-
tages of PCCP include minimal injury to the muscle and
tendon structures [13], shorter surgical time, reduced soft
tissue damage, reduced need for blood transfusion, and
decreased incidence of complications [20].
The purpose of this prospective, multi-center, observa-
tional study was to evaluate the functional and clinical
outcomes at 1 year after the treatment of trochanteric
fractures with the PCCP (Orthofix S.R.L., Verona, Italy) in
8 Italian departments of traumatology.
Materials and methods
From March 2008 to April 2009, 273 consecutive patients
with a stable or unstable proximal femoral fracture, type
31.A1 or 31.A2 according to AO classification, were
enrolled in 8 Italian hospitals and followed up until May
2010. Patients with femoral fractures classified as AO
31.A3 multiple concomitant fractures, pathological frac-
tures, active infection in the surgical site, history of pre-
vious fractures resolved with a reduced function, or
residing outside the geographical region of the treating
hospital were excluded from this study.
PCCP was used for the treatment of trochanteric frac-
tures in all the cases. At admission, demographic and
clinical data, including age, gender, weight, height,
comorbidities (categorized as smoking status, history of
alcoholism, diabetes, dementia, asthma, and heart condi-
tion), domicile (alone, with relatives, or at an institution),
and radiographs, were collected. The requirement of
walking aids, the nature of injury (high energy, low energy,
or pathological nature), the AO fracture classification, the
date of injury, and the date of hospitalization were also
recorded. The ‘‘ASA physical status classification scale’’
[21] was used to assess the condition of the patients before
surgery. Pre-injury activity and post-surgery functional
recovery were evaluated by using the modified Harris Hip
Score (mHHS) [22, 23], a hip function questionnaire used
to assess patient’s ability in normal daily activities and to
provide information about the range-of-movement without
a direct evaluation, present only in the original HHS.
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In literature, there is no widely accepted method for
quantifying the importance of change in HHS. In the past,
the HHS results have been presented regarding the pro-
portion of patients who achieved previously described
clinical end points, identifying four categories by a
decrease of 10 % from the total: excellent 90–100, good
80–89, fair 70–79, and poor \70. These categories,
unfortunately, are not applicable in our patient set because
the pre-surgery hip score is probably often lower than 70,
for the advanced age [24]. More recently, Achten et al. [25]
used the method of the minimal clinically important dif-
ference (MCID) and defined it as a score of 7 points.
However, as reported by Smith et al. [26], the MCID for
the mHHS is unknown. Therefore, on the basis of the 10 %
variation used by Harris, a variation of mHHS C 10 % was
arbitrarily assumed to be clinically significant. Patients
with a negative variation of mHHS from pre-surgery
\10 % were considered well recovered, patients with a
variation C10 and \20 % fairly recovered, and patients
with a variation C20 % poorly recovered.
The lowest hemoglobin (Hb) and hematocrit (Ht) levels
and the number of blood units transfused during preoper-
ative hospitalization were recorded. Data collected intra-
operatively included the delay of surgery, duration of
surgery (skin-to-skin time), fluoroscopic time, number of
transfusions, and occurrence of any intraoperative com-
plications. During the hospital stay, postoperative assess-
ments consisted of the lowest Hb and Ht values, units of
blood transfused, length of skin incisions, pain perceived
by the patient in the surgical region 5 days after surgery as
assessed by a visual analogue scale (VAS), and occurrence
of any complications. Postoperative X-rays were taken.
The total length of the hospital stay and the domicile of the
patient after discharge were also recorded.
Follow-up visits were scheduled according to the stan-
dard practice of the hospitals, namely at 6 weeks
(±7 days), 3 months (±30 days), and 1 year (±30 days),
and involved functional assessment (mHHS), clinical and
radiological assessment, and recording of complications.
Radiological assessments, which included anteroposterior
(AP) and lateral radiographs of the affected hip, were used
to classify the fracture according to the AO classification
and to monitor the progress of fracture healing and possible
complications.
The primary outcome variable was recovery of the pre-
fracture functional status 1 year after the surgery, as previ-
ously described. Secondary outcome variables were blood
loss, surgical time, complications, and mortality (Fig. 1).
Data were analyzed descriptively. Continuous variables
were summarized as mean (SD) and median values, while
categorical variables were summarized as counts and per-
centages. All analyses were performed using SAS version
9.2 (SAS Institute, Cary, NC, USA).
Results
A total of 273 patients were enrolled in the study. Of these,
208 (76.2 %) were women and 65 (23.8 %) were men.
Table 1 shows the baseline characteristics of the patients.
ASA score was 3 or 4 in 72.5 % patients; 44 patients
(16.1 %) had no comorbidities, 104 patients (38.1 %) had 1
comorbidity, 70 patients (25.6 %) had 2 comorbidities, 42
patients (15.4 %) had 3 comorbidities, 10 patients (3.7 %)
had 4 comorbidities, and 3 patients (1.1 %) had 5 comor-
bidities. The most common (117 patients) concomitant
pathology was a cardio-circulatory condition, which
included also hypertension. The vast majority of patients
(90.8 %) had low energy trauma injuries; all fractures were
closed and classified as AO 31.A1 (57.5 %) and 31.A2
(40.7 %), the images were not centrally collected for 5
patients (1,8 %) and the surgeons classified the fractures as
AO31.A without specifying if A1 or A2.
At the end of the 1-year follow-up period, 48 patients
(17.6 %) had died, and 28 patients (10.2 %) were lost to
follow-up. Four patients (1.5 %) were excluded from
functional analysis at 1 year for the following reasons: 2
patients did not come to the final follow-up examination, 1
patient could not answer to the HHS questions because of a
significant cognitive impairment, and 1 patient was re-
operated. Thus, a total of 193 patients (70.3 %) were
available for the final evaluation.
Basal and final mHHS values were available only for
181 patients. mHHS values are reported in Fig. 2. At the
1-year follow-up visit, the mean mHHS reduction was 10.2
points. Patients recovered an average 87 % of their pre-
trauma score; 94 patients (51.9 %) recovered or improved
their pre-fracture mHHS, the score decreased more than
10 % in 30 patients (16.6 %), and more than 20 % in 57
patients (31.5 %). With respect to walking abilities, prior to
surgery 107 patients (59.1 %) did not required any aids,
Fig. 1 Percentages of transfused and not transfused patients
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59 patients (32.6 %) used 1 aid, 14 patients (7.7 %) used
aids, and 1 patient was unable to walk. At the 1-year fol-
low-up, 49.1 % of patients improved or maintained their
walking abilities; 35 patients (19.3 %) walked without
aids, 95 patients (52.5 %) used 1 aid, 33 patients (18.2 %)
used 2 aids, and 18 patients (9.9 %) were unable to walk.
At baseline, 32.2 % of patients lived alone, 59.9 % with
relatives, and 7.9 % in a retirement home. At the 1-year
follow-up visit, 21.5 % of patients lived alone, 62.7 % with
relatives, and 15.8 % in a retirement home. Overall, a low
mortality rate was reported. No patients died intraopera-
tively, 7 patients (2.6 %) died within 30 days, and 20
patients (7.3 %) died within 3 months. At 1-year follow-up
period, the overall mortality rate was 17.6 % (48 patients).
Table 2 shows the intraoperative data. The average time
between trauma and surgery was 4.6 (2.8) days. The
average duration of the fluoroscopic exposure was 44.4
(27.75) s, while the mean duration of surgery was 44.1
(16.55) min. The mean length of the proximal incision was
31 (9.3) mm, while that of the distal incision was 40
(7.2) mm. Intraoperative complications were seen in 6
patients (2.3 %). In 4 patients, the surgeons experienced
difficulties in placing the cephalic screws due to narrow
femoral necks; in 1 patient the drill tip broke; and in 1
patient, the diaphyseal screw was too short. Following
surgery, the patients were discharged after an average
duration of 10.7 (4.99) days; the mean total duration of
hospitalization was 15.3 (5.96) days. The mean pain score
on VAS at day 5 post-surgery was 3.9 (1.38). The mean
reduction in Hb levels between the preoperative and post-
operative lowest value was -2.8 (1.57) g/dL, while that in
Ht levels was -7.9 % (5.74 %). About 13.9 and 7.7 % of
patients required blood transfusion pre-surgery and intra-
operatively, respectively. Furthermore, 51.3 % of patients
did not require transfusions post-surgery, 13.3 % required
only 1 unit of blood, 30.6 % required 2 units, and 4.8 % of
patients required 3 or more units. Overall, an average of 0.9
(1.09) units of blood was transfused post-surgery.
Postoperative complications were seen in 12 patients
(4,3 %). The major complications included 2 fracture col-
lapses (1 associated with a cut-out and another due to a new
fall), 1 case of excessive sliding of the cephalic screw
leading to a partial fracture collapse, and 1 case of backing
out of the diaphyseal screws. The patient with the backing
out of diaphyseal screws was re-operated on; the plate was
removed and a hip prosthesis implanted. Minor complica-
tions included decubitus ulcers in 3 patients, infections at
the surgical incision site in 3 patients, and subcutaneous
hematoma in 2 patients. No delayed union or non-union
was observed in the group.
Discussion
In this study, we assessed the functional and clinical out-
comes in trochanteric fracture patients treated with PCCP.
Our results suggest that treatment with PCCP seems to be
associated with good clinical outcomes, low number of
blood transfusions, and minimum reduced incidence of
intra- and postoperative complications and good functional
Table 1 Baseline characteristics of patients
No. of patients 273
Age
Mean ± SD 82.04 ± 9.93
Median 84
Range 17–104
Gender
Female 208 (76.2 %)
Male 65 (23.8 %)
Comorbidities
Cardiac condition 117 (42.9 %)
Central nervous system condition 62 (22.7 %)
Vascular condition 52 (19.3 %)
Other 127 (46.5 %)
ASA classification
1 6 (2.2 %)
2 69 (25.3 %)
3 173 (63.4 %)
4 25 (9.1 %)
Nature of injury
High energy 15 (5.5 %)
Low energy 248 (90.8 %)
Missing 10 (3.7 %)
Type of fracture
Closed 273 (100 %)
Open 0 (0 %)
AO fracture classification
A1 157 (57.5 %)
A2 111 (40.7 %)
Missing 5 (1.8 %)
Fig. 2 Modified Harris Hip Score pre-surgery and at follow-up visits
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results in the majority of the patients. These findings are
particularly significant considering that 72.5 % of patients
in our study had an ASA score of 3 or 4 with several
comorbidities. The primary goal of fracture treatment is
returning patients to their pre-fracture functional status [4,
5]. The mHHS is considered to be a reliable measure of
functional outcome and accounts for pain and functional
recovery of the patient, including the daily activities and
walking capabilities [22]. In our study, we observed that
51.9 % of patients recovered or improved their pre-fracture
mHHS at 12 months post-surgery. In accordance to our
results, another study [27] showed a good functional
recovery in patients treated with PCCP. In addition, the
same study showed also that PCCP conferred better long-
term functional recovery than DHS. The improved recov-
ery could be a result of pain reduction and decreased soft
trauma associated with the minimally invasive PCCP
technique. Mobility is also an important functional out-
come to be considered after hip surgery [8]. In a prospec-
tive, randomized, controlled clinical trial including patients
with intertrochanteric femoral fractures, 18 % of the
patients treated with Gamma nail achieved their pre-frac-
ture independent mobility [28]. In comparison, 49.1 % of
patients in our study maintained or showed improvement in
their walking abilities at the 1-year follow-up visit. In
addition, 71.8 % of patients were able to walk without
support or with a single aid at the end of 1 year. Laufer
et al. [27] reported that patients treated with PCCP
ambulated with fewer assistive devices in comparison with
those treated with DHS, which suggests that PCCP
enhances the functional abilities of patients. A plausible
explanation for better mobility could be increased fracture
stabilization with the device or lesser damage of perto-
chanteric and thigh muscles. Change in domicile status of
the patients also plays an important role in post-surgical
functional recovery. In 1024 patients treated with the
sliding hip screw, 83 % returned to their own homes at
1 year, but many required extra care as compared to pre-
fracture [29]. Beringer et al. [8] observed that 68 % of
patients were residing at home 1 year after fracture
treatment. We have to consider that in these studies,
patients have lower age or ASA score than our patients. In
our study, 66.6 % of patients living alone pre-surgery
maintained their domicile and continued living alone, at the
1-year follow-up visit. Functional outcomes in patients
treated with PCCP, as evaluated by the improved mHHS,
return to pre-fracture mobility, and maintenance of pre-
surgery domicile status at the 1-year follow-up period
should be considered excellent when compared to other
studies and considering the status of our patients.
Studies have reported shorter surgical time with PCCP
than with DHS and other devices [17, 25, 30, 31]. In a
prospective, randomized study, Janzing et al. [17] reported
surgical duration of 65 min with DHS as compared to
49 min with PCCP. Results from a randomized, controlled
trial by Peyser et al. [30] showed that the mean operative
time in patients treated with PCCP was 67.5 min compared
to 82.7 min in patients treated with CHS. A meta-analysis
of 3 head-to-head trials comparing PCCP and DHS also
reported shorter operative times with PCCP [31]. The
average duration of surgery in our study was 44.1 min,
which is considerably less than those reported in the above-
mentioned studies. A reduced operating time is desirable,
especially in elderly patients with comorbid conditions.
Fluoroscopy time of over 100 s has been reported in most
studies with alternative treatment devices [23, 32]. Saudan
et al. [32] reported a fluoroscopy time of 180 s with DHS,
and Knobe et al. [23] reported a fluoroscopy time of 143 s
with PCCP versus 146 s with DHS and 280 s with the
proximal femoral nail (PFN). The radiation time in our
study was 44.4 s, which is approximately one-third of the
time previously reported and is in line with our shorter
operative time.
Previous studies have shown that the PCCP procedure is
associated with reduced blood loss and reduced transfusion
requirements [13, 30], which leads to faster functional
recovery. In the present study, 51.6 % of patients did not
require postoperative transfusions. On the contrary, treat-
ment of femoral fractures with the DHS has resulted in
higher transfusion rates [31]. The mean decrease in Hb in
Table 2 Intraoperative data
n Mean ± SD Median Range
Days between admission and surgery 273 4.6 ± 2.8 4 0–16
Fluoroscopy time (s) 250 44.4 ± 27.7 39.5 2–220
Duration of surgery (min) 271 44.1 ± 16.5 41 20–180
Hb (g/dL)
Pre-surgery 271 12.1 ± 1.6 12.1 7.6–16.5
During hospitalization 265 9.4 ± 1.5 9.3 3.2–14.2
Ht (%)
Pre-surgery 271 36.3 ± 5.9 36.1 23–94
During hospitalization 265 28.4 ± 4.2 28.1 20–43
Pain at day 5 (VAS) 237 3.9 ± 1.4 4 1–8
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patients in our study was 2.8 g/dL; this is in agreement
with a mean Hb decrease of 3.0 g/dL reported by Peyser
et al. [33]. Brandt et al. [20] showed an absolute risk
reduction of 45 % for blood transfusion with the use of
PCCP. In our study, an average 0.9 units of blood was
transfused, which is lower than the 1.2 units with PCCP
and 1.7 units with CHS reported in a randomized, pro-
spective trial in patients with intertrochanteric hip fractures
by Kosygan et al. [34]. In conclusion, in comparison with
other devices, the treatment of trochanteric fractures with
PCCP reduced the rates of postoperative transfusions,
thanks to the fact that the plate is inserted percutaneously
and there is a minimal blunt dissection of the muscles.
Postoperative pain impedes ambulation, increases patient
discomfort, and hence delays recovery. In the present study,
the pain score on VAS at 5 days post-surgery was 3.9 (1.38).
This result is in agreement with other studies in which it was
demonstrated that patients treated with the PCCP experi-
enced lower pain scores on VAS compared to patients treated
with CHS [27]. Thus, the PCCP appears to be well tolerated
by patients, probably due to less damage to muscles. The
mean duration of hospitalization was reported to be 37 days
and 17 days with the Gamma nail [35] and DHS [36],
respectively. The average duration of hospitalization was
15 days in our study. However, we recognize that duration of
hospitalization can be influenced by organizational matters.
In some cases, the discharge was postponed until an appro-
priate nursing home could be found to begin rehabilitation of
the patient. Short duration of hospitalization in our study
could be attributed to the minimally invasive PCCP tech-
nique, which leads to reduced tissue trauma, faster recovery,
and early discharge.
About 90 % patients did not experience postoperative
complications in our study. Our findings are in agreement
with a retrospective study by Yang et al. [37], in which
82 % of patients did not have postoperative complications.
Brandt et al. [20] also reported less complications with
PCCP than with DHS. A trend toward decreased incidence
of postoperative infections with the PCCP was also
observed in a meta-analysis by Panesar et al. [31].
Overall, the mortality rate in our study was 17.6 %.
Similar values were observed by Bensafi et al. [13]. Mortality
rates ranging from 18 to 33 % have been previously reported
in studies with hip fractures at the end of 1 year [37, 38]. In a
meta-analysis comparing PCCP and DHS, Panesar et al. [31]
reported a decrease in overall mortality with PCCP. A
mortality rate of 11.4 % at 3 months post-surgery was
reported by Berkenbaum et al. [39]. In comparison, our study
was associated with a mortality rate of 7.33 % at 3 months
post-surgery. The low mortality rate in our study can be
attributed to reduced blood loss, surgical trauma, postoper-
ative complications, and accelerated recovery. These results
are particularly important, since 72.5 % patients in our study
had an ASA score of 3 or 4 with a high number of comor-
bidities. The ASA rating is a good predictor of mortality [40–
42]. Patients aged 65–84 years with an ASA score of 3 or 4
have a poorer health and have a higher mortality rate as
compared to patients who are classified as ASA 1 or 2,
regardless of hip fracture. Hip fracture may contribute to this
increased mortality, as frail patients are less likely to survive
the insult of a major fracture and surgery [42]. However, with
the mini-invasive PCCP approach, elderly patients with
associated comorbidities are less exposed to the hazards of
blood transfusion, such as hemodynamic compromise and
potential infections [30]. Thus, PCCP could be the treatment
of choice in highly compromised patients with associated
comorbidities. Paksima et al. [43] reported that patients with
high ASA score of class 3 or 4 were at an increased mortality
risk following hip fractures. The mortality rate at 1 year was
reported to be nine times higher in patients with ASA score 3
and 4 than in healthy or mildly affected patients (ASA scores
1 and 2) [44]. In the present study, in spite of higher pro-
portion of patients with ASA scores 3 and 4, better functional
outcomes and lower mortality rates were observed when
compared to the other studies.
The following study limitations have to be considered
while interpreting our results. This was an observational
study; therefore, surgeons followed the standard care without
additional visits or examinations. There was no control group
included in our study, so we have compared our results with
other published studies. The study was conducted across 8
different hospitals, which may cause variations in the stan-
dard of care during hospitalization and the follow-up period,
resulting in heterogeneity of data. When the radiographs
were not available at the end of 1-year follow-up, the case
report form was compiled with a telephonic interview.
In our study, it has been demonstrated that the treatment
of trochanteric fractures with PCCP is associated with good
recovery of clinical and functional outcomes in terms of the
mHHS, mobility, and domicile status of the patient. PCCP
also offers additional advantages such as reduced surgical
time, blood loss, postoperative complications, and mortal-
ity rate as previously reported.
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